KI67 EXPRESSION AFTER PREOPERATIVE CHEMOTHERAPY IN STAGE II-III BREAST CANCER IS AN INDEPENDENT PREDICTOR OF PATIENT OUTCOME

被引：0
|
作者：
Guameri, V. [1 ]
Piacentini, F. [1 ]
Ficarra, G. [2 ]
Frassoldati, A. [1 ]
Jovic, G. [1 ]
D'Amico, R. [1 ]
Giovannelli, S. [1 ]
Maiorana, A. [2 ]
Conte, P. [3 ]
机构：
[1] Modena Univ Hosp, Dept Hematol & Oncol, Modena, Italy
[2] Modena Univ Hosp, Dept Pathol, Modena, Italy
[3] Univ Modena, Univ Hosp, Dept Onc & Hem, I-41100 Modena, Italy
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [1] Ki67 expression as a predictor of chemotherapy outcome in low-grade serous ovarian cancer
    Grabowski, Jacek P.
    Martinez Vila, Clara
    Richter, Rolf
    Taube, Eliane
    Plett, Helmut
    Braicu, Elena
    Sehouli, Jalid
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (04) : 498 - 503
  • [2] P53 EXPRESSION IS A SIGNIFICANT PREDICTOR OF RESPONSE AND PROGNOSIS IN STAGE II-III BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY
    Guarneri, V.
    Piacentini, F.
    Barbieri, E.
    Frassoldati, A.
    Ficarra, G.
    D'Amico, R.
    Conte, P. F.
    ANNALS OF ONCOLOGY, 2009, 20 : 48 - 48
  • [3] KI67 AS A PREDICTOR OF CLINICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN TRIPLEPOSITIVE BREAST CANCER
    Ben Hamida, Karim
    Houcine, Yoldez
    Maaoui, Amal
    Hamza, Khedija
    Kamoun, Salma
    Ayadi, Senda
    Chargui, Riadh
    Driss, Maha
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A59 - A59
  • [4] Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
    von Minckwitz, Gunter
    Schmitt, Wolfgang D.
    Loibl, Sibylle
    Mueller, Berit M.
    Blohmer, Jens U.
    Sinn, Bruno V.
    Eidtmann, Holger
    Eiermann, Wolfgang
    Gerber, Bernd
    Tesch, Hans
    Hilfrich, Joern
    Huober, Jens
    Fehm, Tanja
    Barinoff, Jana
    Ruediger, Thomas
    Erbstoesser, Erhard
    Fasching, Peter A.
    Karn, Thomas
    Mueller, Volkmar
    Jackisch, Christian
    Denkert, Carsten
    CLINICAL CANCER RESEARCH, 2013, 19 (16) : 4521 - 4531
  • [5] Role of Postmastectomy Radiation After Neoadjuvant Chemotherapy in Stage II-III Breast Cancer
    Fowble, Barbara L.
    Einck, John P.
    Kim, Danny N.
    McCloskey, Susan
    Mayadev, Jyoti
    Yashar, Catheryn
    Chen, Steven L.
    Hwang, E. Shelley
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 83 (02): : 494 - 503
  • [6] LMR predicts outcome in patients after preoperative chemoradiotherapy for stage II-III rectal cancer
    Abe, Shinya
    Kawai, Kazushige
    Nozawa, Hiroaki
    Hata, Keisuke
    Kiyomatsu, Tomomichi
    Morikawa, Teppei
    Watanabe, Toshiaki
    JOURNAL OF SURGICAL RESEARCH, 2018, 222 : 122 - 131
  • [7] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
    Jones, Robin L.
    Salter, Janine
    A'Hern, Roger
    Nerurkar, Ash
    Parton, Marina
    Reis-Filho, Jorge S.
    Smith, Ian E.
    Dowsett, Mitchell
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (01) : 53 - 68
  • [8] Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer
    Tanei, T.
    Shimomura, A.
    Shimazu, K.
    Nakayama, T.
    Kim, S. J.
    Iwamoto, T.
    Tamaki, Y.
    Noguchi, S.
    EJSO, 2011, 37 (02): : 155 - 161
  • [9] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
    Robin L. Jones
    Janine Salter
    Roger A’Hern
    Ash Nerurkar
    Marina Parton
    Jorge S. Reis-Filho
    Ian E. Smith
    Mitchell Dowsett
    Breast Cancer Research and Treatment, 2009, 116 : 53 - 68
  • [10] Prognostic significance of pathologic complete response and Ki67 expression after neoadjuvant chemotherapy in breast cancer
    Yoshioka, Tatsuya
    Hosoda, Mitsuchika
    Yamamoto, Mitsugu
    Taguchi, Kazunori
    Hatanaka, Kanako C.
    Takakuwa, Emi
    Hatanaka, Yutaka
    Matsuno, Yoshihiro
    Yamashita, Hiroko
    BREAST CANCER, 2015, 22 (02) : 185 - 191
12345